A detailed history of Jarislowsky, Fraser LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 19,548 shares of AZN stock, worth $1.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,548
Previous 17,262 13.24%
Holding current value
$1.75 Million
Previous $1.21 Million 24.3%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025

BUY
$68.72 - $82.11 $157,093 - $187,703
2,286 Added 13.24%
19,548 $1.5 Million
Q2 2025

Jul 15, 2025

BUY
$64.87 - $75.0 $167,364 - $193,500
2,580 Added 17.57%
17,262 $1.21 Million
Q1 2025

May 12, 2025

SELL
$65.37 - $77.96 $89,230 - $106,415
-1,365 Reduced 8.51%
14,682 $1.08 Million
Q4 2024

Feb 14, 2025

BUY
$63.2 - $79.58 $230,996 - $290,864
3,655 Added 29.49%
16,047 $1.05 Million
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $132,409 - $151,319
-1,727 Reduced 12.23%
12,392 $965,000
Q2 2024

Aug 12, 2024

BUY
$66.81 - $80.83 $2,405 - $2,909
36 Added 0.26%
14,119 $1.1 Million
Q1 2024

Sep 30, 2024

BUY
$61.03 - $69.57 $141,589 - $161,402
2,320 Added 19.72%
14,083 $954,000
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $141,589 - $161,402
2,320 Added 19.72%
14,083 $954,000
Q4 2023

Sep 30, 2024

SELL
$61.89 - $69.28 $145,812 - $163,223
-2,356 Reduced 16.69%
11,763 $792,000
Q4 2023

Feb 12, 2024

SELL
$61.89 - $69.28 $4,579 - $5,126
-74 Reduced 0.63%
11,763 $792,000
Q3 2023

Sep 30, 2024

SELL
$64.85 - $71.7 $147,987 - $163,619
-2,282 Reduced 16.16%
11,837 $801,000
Q3 2023

Nov 06, 2023

BUY
$64.85 - $71.7 $196,171 - $216,892
3,025 Added 34.33%
11,837 $801,000
Q2 2023

Sep 27, 2024

SELL
$69.91 - $75.81 $371,012 - $402,323
-5,307 Reduced 37.59%
8,812 $630,000
Q2 2023

Jul 19, 2023

BUY
$69.91 - $75.81 $616,046 - $668,037
8,812 New
8,812 $630,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jarislowsky, Fraser LTD Portfolio

Follow Jarislowsky, Fraser LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.